High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

• Главные авторы: Yanfang Zhao (Автор), Wenjia Su (Автор), Guohua Liang (Автор), Xiaoyu Shan (Автор), Weiwei Ma (Автор), Dabei Tang (Автор), Liru Li (Автор), Xingjian Niu (Автор), Shu Zhao (Автор), Qingyuan Zhang (Автор), Wenhui Zhao (Автор)
• Формат: ‌
• Опубликовано: BMC, 2021-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin. Metho...